ENANTA PHARMACEUTICALS, INC Operating Lease Liability
ENANTA PHARMACEUTICALS, INC (ENTA) had Operating Lease Liability of $57.90 million as of 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-19
- 2025-09-30: Operating Lease, Liability $57.90M.
- 2025-06-30: Operating Lease, Liability $58.05M.
- 2025-03-31: Operating Lease, Liability $58.73M.
- 2024-12-31: Operating Lease, Liability $57.46M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-09-30 | $57.90M 10-K · filed 2025-11-19 | |
| 2025-06-30 | $58.05M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $58.73M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $57.46M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $55.47M 10-K · filed 2024-11-27 | |
| 2024-06-30 | $50.57M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $46.99M 10-Q · filed 2024-05-08 | |
| 2023-09-30 | $26.51M 10-K · filed 2024-11-27 | |
| 2022-09-30 | $25.26M 10-K · filed 2023-11-22 | |
| 2021-09-30 | $5.33M 10-K · filed 2022-11-23 | |
| 2020-09-30 | $8.10M 10-K · filed 2021-11-24 | |
| 2020-06-30 | $8.81M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.09M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $9.12M 10-Q · filed 2020-02-10 | |
| 2019-10-01 | $7.15M 10-K · filed 2021-11-24 | $8.62M 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |